47.73.Z - Retail sale of pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
10.89.Z - Production of other food products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,8 | 0,8 | 0,8 | 5,8 |
Gross profit (loss) | 0,7 | 0,7 | 0,8 | 14,3 |
EBITDA | 0,7 | 0,6 | 0,8 | 18,4 |
Short time liabilities | 3,9 | 4,3 | 5,2 | 20,7 |
Other operating costs | 0,2 | 0,2 | 0,1 | -30,6 |
Equity capital | 1,5 | 1,6 | 1,7 | 5,5 |
Operating profit (EBIT) | 0,6 | 0,6 | 0,7 | 15,5 |
Assets | 5,6 | 6,2 | 7,2 | 15,9 |
Net profit (loss) | 0,5 | 0,6 | 0,7 | 15,2 |
Cash | 0 | 0,1 | 0,1 | 15,5 |
Net income from sale | 18,2 | 22,7 | 28,2 | 24 |
Liabilities and provisions for liabilities | 4,1 | 4,7 | 5,6 | 19,4 |
Working assets | 5,4 | 5,8 | 6,9 | 17,6 |
Other income costs | 0 | 0 | 0 | -38,4 |
Depreciation | 0 | 0 | 0,1 | 55,2 |
% | % | % | p.p. | |
Profitability of capital | 32,4 | 36,4 | 39,7 | 3,3 |
Equity capital to total assets | 26,6 | 25,3 | 23 | -2,3 |
Gross profit margin | 3,6 | 3,2 | 3 | -0,2 |
EBITDA Margin | 3,7 | 2,8 | 2,7 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 78 | 70 | 68 | -2 |
Current financial liquidity indicator | 1.387272596359253 | 1.3454976081848145 | 1.3107666969299316 | 0 |
Net dept to EBITDA | -0.05156661197543144 | -0.08936754614114761 | -0.08745826035737991 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane